title: [The new limitations of the Italian Regulatory Agency on Drugs].
abstract: In Italy the reimbursement of few free-of-charge drugs is limited to subgroups of patients or to one of the approved indications. In February 2001 new rules will become mandatory for Italian physicians. The text of the new rules related to drugs mostly used by cardiologists (levocarnitine, ticlopidine, hypolipemic drugs) is reported.
authors.affiliation: Divisione Universitaria di Cardiologia, Università degli Studi, Torino. marcobobbio@libero.it
authors.forename: M
authors.initials: M
authors.lastname: Bobbio
mesh_terms: D006331:Heart Diseases / Q000188:drug therapy; D006801:Humans; D007558:Italy; D007880:Legislation, Drug
vernacular_title: Le nuove "note" limitative della Commissione Unica del Farmaco.